bluebird bio, Inc. (BLUE)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EST
After hours:
| Previous close | 6.23 |
| Open | 6.20 |
| Bid | 0.00 x 3200 |
| Ask | 0.00 x 1800 |
| Day's range | 6.15 - 6.49 |
| 52-week range | 2.87 - 8.58 |
| Volume | |
| Avg. volume | 3,761,103 |
| Market cap | 646.356M |
| Beta (5Y monthly) | 0.98 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -10.43 |
| Earnings date | 02 Mar 2023 - 06 Mar 2023 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 7.33 |
- Zacks
Zacks.com featured highlights include bluebird bio, Pros Holdings and Norwegian Cruise Line
bluebird bio, Pros Holdings and Norwegian Cruise Line are part of the Zacks Screen of the Week article.
- Motley Fool
Better Biotech Buy: Bluebird Bio or CRISPR Therapeutics?
Last year paved the way for a potential breakthrough this year for both gene-editing biotech companies.
- Business Wire
bluebird bio, Inc. Announces Pricing of $120 Million Public Offering of Common Stock
SOMERVILLE, Mass., January 19, 2023--bluebird bio, Inc. (Nasdaq: BLUE) ("bluebird") today announced the pricing of its underwritten public offering of 20,000,000 shares of its common stock at a public offering price of $6.00 per share, before deducting underwriting discounts and commissions. bluebird also granted the underwriters a 30-day option to purchase up to an additional 3,000,000 shares of its common stock at the public offering price per share, less underwriting discounts and commissions
© 2023 Yahoo. All rights reserved.
